# CORRESP — Qualigen Therapeutics, Inc.  (AIXC)  (CIK 0001460702)

> <strong>Qualigen Therapeutics, Inc.  (AIXC)  (CIK 0001460702) → SEC staff</strong> · filed 2025-09-23 · ticker AIXC · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001493152-25-014622
- **Form:** CORRESP
- **Filer:** Qualigen Therapeutics, Inc.  (AIXC)  (CIK 0001460702)
- **CIK:** 0001460702
- **Ticker:** AIXC
- **Filed:** 2025-09-23
- **SIC industry:** 2834
- **HQ:** California, CA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1460702/000149315225014622/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1460702&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Qualigen Therapeutics, Inc.  (AIXC)  (CIK 0001460702)

- UPLOAD — 2025-09-23 — /comment-letter/0000000000-25-010354

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Qualigen Therapeutics, Inc.  (AIXC)  (CIK 0001460702) (CIK 0001460702), filed 2025-09-23, accession 0001493152-25-014622. Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/comment-letter/0001493152-25-014622.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*